Skip to main content

Multi-Center Phase III Clinical Trials and NCI Cooperative Groups Workshop Summary (2009) / Chapter Skim
Currently Skimming:

Appendix A: Workshop Agenda
Pages 111-116

The Chapter Skim interface presents what we've algorithmically identified as the most significant single chunk of text within every page in the chapter.
Select key terms on the right to highlight them within pages of the chapter.


From page 111...
... Abrams, NCI "NCI's Clinical Trials Program" 111
Read the entire page →
From page 112...
... Califf, Duke University "Organization of Multi-Center Trials: Are Oncopolitics Different than Other Clinical Research Politics" Renzo Canetta, Bristol–Myers Squibb "Industry-Sponsored Multi-Center Trials" Alan Keller, Cancer Care Associates "Multi-Center Clinical Trials in the Community: Models and Methods: What Works, What Doesn't, and Why" Lunch Break 12:45 pm – 1:30 pm Session 2: Patient recruitment and physician participation 1:30 pm – 5:15 pm ÿ Session 2A: panel on academic challenges 1:30 pm – 3:00 pm Moderator: John Mendelsohn, M
Read the entire page →
From page 113...
... Feldmann, Moses Cone Regional Cancer Center "Community Cancer Centers: The Crisis in Clinical Trials" Richard Kaplan, National Cancer Research Network, United Kingdom  "Publicly Funded Cooperative Groups Working with Industry" Deborah Collyar, Patient Advocates in Research "Connecting Clinical Trials to People" Adjourn Day 1 5:15 pm
Read the entire page →
From page 114...
... Doroshow, National Institutes of Health "NIH Perspective" Gwendolyn Fyfe, Genentech "A Perspective on How to Quickly Define Data Standards" Robert L Comis, Coalition of National Cancer Cooperative Groups  "The Role of Cooperative Groups in Establishing Safety and Efficacy" Panel Discussion: James Doroshow, Gwendolyn Fyfe, Robert Comis, and Richard Pazdur, FDA Break 10:00 am – 10:15 am Session 4: Costs/Payments 10:15 am – 12:45 pm Moderator: Robert L
Read the entire page →
From page 115...
... Newcomer, UnitedHealthcare "An Insurer's View: Paying for Clinical Trials" Wrap-up 12:45 pm – 1:00 pm John Mendelsohn and Hal Moses Adjourn Day 2 1:00 pm
Read the entire page →

Key Terms

  • cancer center
  • phase iii
  • iii clinical
  • vanderbilt university
  • hal moses

  • james cancer
  • cancer hospital
  • institutions conducting
  • community cancer
  • research network

  • cancer cooperative
  • delaware christiana
  • lurie comprehensive
  • conducting clinical
  • cancer research

  • university comprehensive
  • quickly define
  • career advancement
  • benson iii
  • collection standards

  • regional cancer
  • comprehensive cancer
  • james doroshow
  • opening oncology
  • connecting clinical

  • trials contributions
  • anderson cancer
  • richard kaplan
  • moses cone
  • cancer care


    • This material may be derived from roughly machine-read images, and so is provided only to facilitate research.
    More information on Chapter Skim is available.